Images

Filter by

Table 2 Overview of the Sodium–Glucose Cotransporter Inhibitors and Glucagonlike Peptide 1 Receptor Agonists Clinical Trials in Patients with Heart Failure
Table 2: Overview of the Sodium–Glucose Cotransporter Inhibitors and Glucagonlike Peptide-1 Receptor Agonists Clinical Trials in Patients with Heart Failure
Figure 2 Summary of Major Clinical Trials of Sodium–Glucose Co transporter Inhibitors and Glucagon like Peptide 1 Receptor Agonists with Their Proven Clinical Benefits
Figure 2: Summary of Major Clinical Trials of Sodium–Glucose Co-transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists with Their Proven Clinical Benefits
Table 1 Overview of the Key Sodium–Glucose Cotransporter Inhibitors Cardiovascular and Kidney Outcomes Trials in Patients with Type 2 Diabetes
Table 1: Overview of the Key Sodium–Glucose Cotransporter Inhibitors Cardiovascular and Kidney Outcomes Trials in Patients with Type 2 Diabetes
Figure 1 Mechanism of Glucose Reabsorption in the Proximal Convoluted Tubule of the Nephron
Figure 1: Mechanism of Glucose Reabsorption in the Proximal Convoluted Tubule of the Nephron
Table 3 Non invasive Multiparameter guided Management
Table 3: Non-invasive Multiparameter-guided Management
Table 2 Cardiac Implantable Electronic Device based Multiparameter guided Management
Table 2: Cardiac Implantable Electronic Device-based Multiparameter-guided Management
Table 1 Haemodynamic guided Management
Table 1: Haemodynamic-guided Management
Figure 2 Invasive Pressure Monitoring Devices and Clinical Trials Assessing Their Safety and Efficacy
Figure 2: Invasive Pressure Monitoring Devices and Clinical Trials Assessing Their Safety and Efficacy
Figure 1 Guideline directed Medical Therapy centred Personalised Therapy in Heart Failure
Figure 1: Guideline-directed Medical Therapy-centred Personalised Therapy in Heart Failure
Central Illustration Heart Failure Management
Central Illustration: Heart Failure Management
Figure 5 Multivariable Mendelian Randomisation and Mediation Analysis for BMI and Non ischaemic Cardiomyopathy
Figure 5: Multivariable Mendelian Randomisation and Mediation Analysis for BMI and Non-ischaemic Cardiomyopathy
Figure 4 Genetically Predicted Association of Eight Obesity related Traits Association with Risk of LVIDd and LVM
Figure 4: Genetically Predicted Association of Eight Obesity-related Traits: Association with Risk of LVIDd and LVM